New Hampshire SB 32: reestablishing the commission to study greater transparency in pharmaceutical costs and drug rebate programs.

Status: Inexpedient to Legislate, MA, VV === BILL KILLED ===; 03/21/2019; SJ 9 (as of 2019-03-21)

State: New Hampshire · Session: 2019 · Bill: SB 32

View New Hampshire SB 32 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.